A bacterial biosensor encoding a genetically modified LuxR receptor exhibits improved detection of Pseudomonas aeruginosa's biomarker molecule 2-aminoacetophenone.

2-Aminoacetophneone (2-AA) is a volatile molecule produced in high amounts by the opportunistic pathogen Pseudomonas aeruginosa. We have previously shown that 2-AA activates the quorum sensing (QS) LuxR receptor of Aliivibrio fischeri. In the present study we were able to improve LuxR's affinity and detection limit for 2-AA by genetic modification of three amino acids within the binding pocket of the receptor. Expression of the modified LuxR receptor in a luminescent bacterial biosensor provided an efficient detection assay of 2-AA in clinical P. aeruginosa strains isolated from blood and lung infections, as well as in phlegm samples obtained from subjects suffering from lung infections.

[1]  Noam Sobel,et al.  Smelling Pseudomonas aeruginosa infections using a whole-cell biosensor - An alternative for the gold-standard culturing assay. , 2018, Journal of biotechnology.

[2]  M. Srinivasan,et al.  Environmentally Endemic Pseudomonas aeruginosa Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers , 2016, mSphere.

[3]  T. Yarnitzky,et al.  Pseudomonas aeruginosa activates the quorum sensing LuxR response regulator through secretion of 2-aminoacetophenone. , 2015, Chemical communications.

[4]  R. Nir-Paz,et al.  Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  R. Tompkins,et al.  The Quorum Sensing Volatile Molecule 2-Amino Acetophenon Modulates Host Immune Responses in a Manner that Promotes Life with Unwanted Guests , 2012, PLoS pathogens.

[6]  David Smith,et al.  Quantification of hydrogen cyanide and 2-aminoacetophenone in the headspace of Pseudomonas aeruginos , 2012 .

[7]  Pedro V. Baptista,et al.  Noble Metal Nanoparticles for Biosensing Applications , 2012, Sensors.

[8]  Scott R. Miller,et al.  Genotypic and Phenotypic Variation in Pseudomonas aeruginosa Reveals Signatures of Secondary Infection and Mutator Activity in Certain Cystic Fibrosis Patients with Chronic Lung Infections , 2011, Infection and Immunity.

[9]  L. Rahme,et al.  A Quorum Sensing Regulated Small Volatile Molecule Reduces Acute Virulence and Promotes Chronic Infection Phenotypes , 2011, PLoS pathogens.

[10]  R. Laing,et al.  2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung , 2010, BMC pulmonary medicine.

[11]  M. Schuster,et al.  Instantaneous Within-Patient Diversity of Pseudomonas aeruginosa Quorum-Sensing Populations from Cystic Fibrosis Lung Infections , 2009, Infection and Immunity.

[12]  F. Stapleton,et al.  Risk Factors and Causative Organisms in Microbial Keratitis , 2008, Cornea.

[13]  David A. D'Argenio,et al.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Liljefors,et al.  The LuxR receptor: the sites of interaction with quorum-sensing signals and inhibitors. , 2005, Microbiology.

[15]  A. Shiao,et al.  Ear Problems in Swimmers , 2005, Journal of the Chinese Medical Association : JCMA.

[16]  M. Kollef,et al.  Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment , 2005, Antimicrobial Agents and Chemotherapy.

[17]  K. E. Hill,et al.  A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. , 2005, The Journal of antimicrobial chemotherapy.

[18]  S. Rice,et al.  Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. , 2004, Investigative ophthalmology & visual science.

[19]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[20]  T. Marrie,et al.  Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  E. Lowbury,et al.  Use of an improved cetrimide agar medium and other culture methods for Pseudomonas aeruginosa , 1965, Journal of clinical pathology.